Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wallach

Showing results (321-330 of 457) with videos related to

Pageof 46
Sort By:
Presse Medicale (Paris, France : 1983)|September 24, 1988
[Association of Hansen's disease and human deficiency virus infection. 2 cases]F Janssen, D Wallach, M A Khuong, et al.
Journal of General Internal Medicine|July 18, 2019
Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment AgenciesAlexander C Egilman, Joshua D Wallach, Sanket S Dhruva, et al.
Clinical Trials (London, England)|April 17, 2021
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 1, 1995
Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infectionA Kalinkovich, R Geleziunas, O Kemper, et al.
JAMA Internal Medicine|December 8, 2025
Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments ActHarry Doernberg, Joshua D Wallach, Molly M Jeffery, et al.
Lymphokine Research|January 1, 1989
Mechanisms which take part in regulation of the response to tumor necrosis factorD Wallach, H Holtmann, D Aderka, et al.
JAMA Network Open|May 1, 2024
Premarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication ApprovalsMaryam Mooghali, Ayman Mohammad, Joshua D Wallach, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Tumor necrosis factor receptors of the monocyte derived Langerhans cell phenotype "MoLC"G Rossi, S Alijagic, D Schoeler, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1983
[Nocardiosis with pulmonary and subcutaneous localizations during the treatment of bullous pemphigoid]D Wallach, E Aubinière, A Konqui, et al.
Journal of Adolescent and Young Adult Oncology|April 24, 2013
Understanding Technology and Human Interaction to Catalyze Oncofertility and Adolescent and Young Adult Oncology ResearchKate E Waimey, Angela D Krausfeldt, Robert L Taylor, et al.
Pageof 46

Showing results (321-330 of 457) with videos related to

Sort By:
Pageof 46
Presse Medicale (Paris, France : 1983)|September 24, 1988
[Association of Hansen's disease and human deficiency virus infection. 2 cases]F Janssen, D Wallach, M A Khuong, et al.
Journal of General Internal Medicine|July 18, 2019
Medicare Spending on Drugs and Biologics Not Recommended for Coverage by International Health Technology Assessment AgenciesAlexander C Egilman, Joshua D Wallach, Sanket S Dhruva, et al.
Clinical Trials (London, England)|April 17, 2021
US Food and Drug Administration utilization of postmarketing requirements and postmarketing commitments, 2009-2018Joshua J Skydel, Audrey D Zhang, Sanket S Dhruva, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|September 1, 1995
Increased soluble tumor necrosis factor receptor expression and release by human immunodeficiency virus type 1 infectionA Kalinkovich, R Geleziunas, O Kemper, et al.
JAMA Internal Medicine|December 8, 2025
Postmarket Drug Safety-Related Actions Before and After the US Food and Drug Administration Amendments ActHarry Doernberg, Joshua D Wallach, Molly M Jeffery, et al.
Lymphokine Research|January 1, 1989
Mechanisms which take part in regulation of the response to tumor necrosis factorD Wallach, H Holtmann, D Aderka, et al.
JAMA Network Open|May 1, 2024
Premarket Evidence and Postmarketing Requirements for Real-Time Oncology Review Indication ApprovalsMaryam Mooghali, Ayman Mohammad, Joshua D Wallach, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Tumor necrosis factor receptors of the monocyte derived Langerhans cell phenotype "MoLC"G Rossi, S Alijagic, D Schoeler, et al.
Annales De Dermatologie Et De Venereologie|January 1, 1983
[Nocardiosis with pulmonary and subcutaneous localizations during the treatment of bullous pemphigoid]D Wallach, E Aubinière, A Konqui, et al.
Journal of Adolescent and Young Adult Oncology|April 24, 2013
Understanding Technology and Human Interaction to Catalyze Oncofertility and Adolescent and Young Adult Oncology ResearchKate E Waimey, Angela D Krausfeldt, Robert L Taylor, et al.
Pageof 46